Review article · 2025
Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies
ChemBioChem, 26(22), e202500305 · Published 26 September 2025 · DOI 10.1002/cbic.202500305
In brief
“Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies” is a 2025 review article by Yutaka Matsuda and 2 co-authors, published in ChemBioChem. OpenAlex counts 48 citations as of 21 November 2026, which puts it in the top 4% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 48
- Most cited in
- 2026 (44)
- Field-weighted impact
- 3.16
- References
- 98
- Authors
- 3
Abstract
Antibody-drug conjugates (ADCs) represent a promising class of targeted cancer therapies, with the potential to improve treatment precision because of their unique mechanism of selectively delivering cytotoxic payloads (PLs) to tumor cells. ADCs combine a monoclonal antibody directed against a tumor-associated antigen with a potent cytotoxic PL via a covalent linker which connects the PL… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Matsuda, Y., Chang, J. R., & Mendelsohn, B. A. (2025). Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies. ChemBioChem, 26(22), e202500305. https://doi.org/10.1002/cbic.202500305
MLA 9
Matsuda, Yutaka, et al. “Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies.” ChemBioChem, vol. 26, no. 22, 2025, p. e202500305. https://doi.org/10.1002/cbic.202500305.
Chicago
Matsuda, Yutaka, Jenny R. Chang, and Brian A. Mendelsohn. 2025. “Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies.” ChemBioChem 26 (22): e202500305. https://doi.org/10.1002/cbic.202500305.
Harvard
Matsuda, Y., Chang, J. R. and Mendelsohn, B. A. (2025) ‘Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies’, ChemBioChem, 26(22), p. e202500305. doi:10.1002/cbic.202500305.
IEEE
Y. Matsuda, J. R. Chang, and B. A. Mendelsohn, “Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies,” ChemBioChem, vol. 26, no. 22, p. e202500305, 2025, doi: 10.1002/cbic.202500305.
BibTeX
@article{matsuda2025advanced,
title = {{Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies}},
author = {Matsuda, Yutaka and Chang, Jenny R. and Mendelsohn, Brian A.},
journal = {ChemBioChem},
year = {2025},
volume = {26},
number = {22},
pages = {e202500305},
doi = {10.1002/cbic.202500305},
url = {https://doi.org/10.1002/cbic.202500305}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- antibody-drug conjugates
- linker chemistry
- site-specific conjugation
- cleavable linkers
- cytotoxic payloads
- lysine conjugation
- cysteine conjugation
- microbial transglutaminase
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Matsuda, Y., Chang, J. R., & Mendelsohn, B. A. (2025). Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies. ChemBioChem, 26(22), e202500305. https://doi.org/10.1002/cbic.202500305
How many times has this paper been cited?
48 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Yutaka Matsuda, Jenny R. Chang, Brian A. Mendelsohn.
What is the DOI of this paper?
10.1002/cbic.202500305, permanently at https://doi.org/10.1002/cbic.202500305. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.